Literature DB >> 16983096

Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA.

Meir Shamay1, Anita Krithivas, Jun Zhang, S Diane Hayward.   

Abstract

The Kaposi's sarcoma-associated herpesvirus LANA protein is expressed in all Kaposi's sarcoma-associated herpesvirus-infected cells, including the tumor cells of endemic and AIDS-associated Kaposi sarcoma, primary effusion lymphoma, and Castleman disease. LANA modulates cell gene expression, but the mechanisms of LANA-mediated transcriptional reprogramming are poorly understood. LANA-repressed cell genes were identified by using retroviral-transduced telomerase-immortalized microvascular endothelial cells. Transciptional repression of targeted genes was relieved by treatment with the methyltransferase inhibitor 5-aza-2'-deoxycytidine, suggesting a role for DNA methylation in repression. We found that LANA coprecipitated with DNA methyltransferases (Dnmts) and recruited endogenous DNA methyltransferase activity from the cell extract. LANA preferentially relocalized Dnmt3a from the nuclear matrix into the chromatin fraction. Further, LANA associated with repressed cellular promoters, recruited Dnmt3a to DNA, and facilitated de novo promoter methylation of a down-regulated gene, cadherin 13 (H-cadherin). The data provide an example of promoter-specific epigenetic DNA modification through viral protein recruitment of de novo Dnmt activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16983096      PMCID: PMC1599998          DOI: 10.1073/pnas.0604469103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  69 in total

1.  DNA methyltransferases get connected to chromatin.

Authors:  Wendy A Burgers; François Fuks; Tony Kouzarides
Journal:  Trends Genet       Date:  2002-06       Impact factor: 11.639

2.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.

Authors:  Huaxin Si; Erle S Robertson
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 3.  The pleiotropic effects of Kaposi's sarcoma herpesvirus.

Authors:  Thomas F Schulz
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

Review 4.  DNA methylation and gene silencing in cancer.

Authors:  Stephen B Baylin
Journal:  Nat Clin Pract Oncol       Date:  2005-12

5.  Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b.

Authors:  M Suzuki; T Yamada; F Kihara-Negishi; T Sakurai; E Hara; D G Tenen; N Hozumi; T Oikawa
Journal:  Oncogene       Date:  2006-04-20       Impact factor: 9.867

6.  Evidence for an instructive mechanism of de novo methylation in cancer cells.

Authors:  Ilana Keshet; Yeshayahu Schlesinger; Shlomit Farkash; Eyal Rand; Merav Hecht; Eran Segal; Eli Pikarski; Richard A Young; Alain Niveleau; Howard Cedar; Itamar Simon
Journal:  Nat Genet       Date:  2006-02       Impact factor: 38.330

7.  p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients.

Authors:  Paola Ulivi; Wainer Zoli; Daniele Calistri; Francesco Fabbri; Anna Tesei; Marco Rosetti; Marta Mengozzi; Dino Amadori
Journal:  J Cell Physiol       Date:  2006-03       Impact factor: 6.384

8.  DNA motifs associated with aberrant CpG island methylation.

Authors:  F Alex Feltus; Eva K Lee; Joseph F Costello; Christoph Plass; Paula M Vertino
Journal:  Genomics       Date:  2006-02-17       Impact factor: 5.736

9.  Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway.

Authors:  M T McCabe; J A Low; M J Imperiale; M L Day
Journal:  Oncogene       Date:  2006-05-04       Impact factor: 9.867

10.  Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.

Authors:  A Leiblich; S S Cross; J W F Catto; J T Phillips; H Y Leung; F C Hamdy; I Rehman
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 9.867

View more
  89 in total

1.  Regulation of Nm23-H1 and cell invasiveness by Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhiqiang Qin; Lu Dai; Bryan Toole; Erle Robertson; Chris Parsons
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 2.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

3.  A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.

Authors:  Meir Shamay; Jianyong Liu; Renfeng Li; Gangling Liao; Li Shen; Melanie Greenway; Shaohui Hu; Jian Zhu; Zhi Xie; Richard F Ambinder; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

Review 4.  Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.

Authors:  Shara N Pantry; Peter G Medveczky
Journal:  Semin Cancer Biol       Date:  2009-02-21       Impact factor: 15.707

Review 5.  Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Authors:  Emily Cousins; John Nicholas
Journal:  Recent Results Cancer Res       Date:  2014

6.  Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma.

Authors:  Sarah Leonard; Wenbin Wei; Jennifer Anderton; Martina Vockerodt; Martin Rowe; Paul G Murray; Ciaran B Woodman
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 7.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.

Authors:  Magdalena Weidner-Glunde; Giuseppe Mariggiò; Thomas F Schulz
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

8.  Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.

Authors:  Qiuhua Li; Meilan He; Fuchun Zhou; Fengchun Ye; Shou-Jiang Gao
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

Review 9.  Viral manipulation of the host epigenome for oncogenic transformation.

Authors:  Roberto Ferrari; Arnold J Berk; Siavash K Kurdistani
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

10.  Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.

Authors:  Joanna Laurson; Sadaf Khan; Rachel Chung; Karen Cross; Kenneth Raj
Journal:  Carcinogenesis       Date:  2010-02-01       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.